APY Aspyra,

Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Renaissance Radiology Medical Group, Inc., a leading provider of outpatient diagnostic services throughout southern California, to provide Aspyra’s integrated AccessRAD RIS/PACS solution.

Headquartered in Pomona, California with twenty-four reading radiologists throughout the state – Renaissance Radiology performs approximately one million studies per year, providing a full array of advanced medical imaging technologies, including Magnetic Resonance Imaging (MRI), CT (Computed Tomography), Fluoroscopy, Digital Mammography, 3D and 4D Obstetrical Ultrasound and Bone Densitometry.

“Because we deal with a large volume of examinations from multiple locations everyday, it was important to us that we selected an integrated RIS/PACS vendor that was able to not only deliver the images to the radiologists consistently and seamlessly, but allow a level of customization that insured the right films were reaching the right radiologists and that they could be viewed according to the individual physician preferences,” stated Monika Kief-Garcia, CEO for Renaissance Radiology Medical Group. She continued, “The added ability to track and trend workflow from sites and referring physicians and facilitate billing was a dream come true to the office staff. Aspyra was able to demonstrate what no other vendor could.”

“Renaissance Radiology’s business model represents a trend in the imaging center industry,” stated Rodney Schutt, Aspyra’s CEO. He continued, “No longer is a radiologist reading for a single location. Instead they are required to read a higher volume of images from various locations. In addition, many centers have lost revenue because their legacy systems are unable to process the foreign studies, or manage the turnaround and distribution of clinical reports due to the increase in volume. Aspyra’s RIS/PACS will give Renaissance Radiology the functionality and peace of mind to advance their business forward.”

Aspyra’s PACS, Specialty PACS and RIS/PACS solutions are designed to meet the needs of acute care hospitals, enterprise-wide delivery networks, medium to large imaging centers, and orthopedic group practices, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow.

About Aspyra

Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com.

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra’s markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of today the date of this press release, including management's own knowledge and assessment of the Company’s industry and competition. Factors that could cause Aspyra’s actual results to differ materially from these forward-looking statements include among others: the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements

Aspyra (AMEX:APY)
Historical Stock Chart
From Nov 2024 to Dec 2024

Aspyra (AMEX:APY)
Historical Stock Chart
From Dec 2023 to Dec 2024